Format

Send to

Choose Destination
Hist Psychiatry. 2007 Mar;18(1):39-60.

The history of clozapine and its emergence in the US market: a review and analysis.

Author information

1
Department of Psychiatry, University of Rochester, School of Medicine and Dentistry, 300 Crittenden Blvd, Rochester, NY 14642, USA. john_crilly@urmc.rochester.edu

Abstract

Clozapine is known as the first 'atypical' medication and is effective in people who have treatment-resistant schizophrenia. Its 1990 emergence in the USA was marked by considerable controversy over its high cost, due in large part to having been both the first new antipsychotic medication to come to market in over a decade and the need for comprehensive safety monitoring within a decentralized health system. This paper traces the history of clozapine's discovery and development in Europe, its part in the 1975 Finnish agranulocytosis scare, and its subsequent volatile emergence in the USA. Analyses examine peripheral forces at the time, particularly the influence of political, corporate, medical and societal forces which shaped its market course.

PMID:
17580753
DOI:
10.1177/0957154X07070335
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center